Hemogenyx Raises Capital via Warrant Exercise
LONDON, U.K., Feb. 23, 2026 — Hemogenyx Pharmaceuticals PLC announced the exercise of warrants and subsequent issue of new...
Mergers & Acquisitions for New Therapy
VB Spine to Acquire Augmedics AR Spine Navigation Platform
NEW YORK, NY & CHICAGO, IL, Feb. 16, 2026 — VB Spine LLC announced it has entered into a...
Worldwide Completes Catalyst CRO Acquisition Deal
RESEARCH TRIANGLE PARK, N.C., and NOTTINGHAM, U.K., Feb. 16, 2026 — Global contract research organization Worldwide Clinical Trials has...
Alkermes Expands Sleep Portfolio With Avadel Buy
DUBLIN, Feb. 12, 2026 — Alkermes plc has completed its acquisition of Avadel Pharmaceuticals plc, accelerating its strategic entry...
BD–Waters Deal Expands Life Sciences Analytics
FRANKLIN LAKES, N.J., Feb. 9, 2026 — Becton, Dickinson and Company (BD) announced the successful completion of the previously...
Kingsway Acquires Lobe Miracle® Consumer Care Brand
BRISTOL, Tenn., Feb. 5, 2026 — Kingsway Pharmaceuticals, LLC announced the acquisition of the Lobe Miracle® brand from CCA...
Red Nucleus Acquires Bridge to Strengthen HEOR Expertise
BOSTON, Feb. 2, 2026 — Red Nucleus, a global strategic partner to pharmaceutical and biotechnology companies, announced a definitive...
XenoTherapeutics Completes Acquisition of Repare Therapeutics
Montreal, Canada | January 29, 2026 — Repare Therapeutics Inc., a clinical-stage precision oncology company, has completed its previously...
OSR Holdings Advances MedTech Platform With Woori IO Deal
BELLEVUE, Wash., January 27, 2026 — OSR Holdings, Inc. (NASDAQ: OSRH) has completed the acquisition of Woori IO Co.,...
Evestia Clinical Expands Global CRO Platform With ICRC-Weyer
LONDON, UNITED KINGDOM | January 27, 2026 — Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO),...